Paediatric clinical trials are critical to ensure that medications prescribed to children are safe and effective. However, evidence-based dosing and labelling of such medications remain limited, and most clinical trials in paediatrics fail. Factors for lack of trial completion include performance at site level (limited patient recruitment, limited site staff experience and lack of infrastructure),…
DetailsFundamental steps in the development of the Czech National Hub began more systematically in 2019. Since then, the Hub has been involved in several national paediatric research projects.
DetailsOne year of the no-cost extension of the c4c project has been approved by IHI (Innovative Health Initiative), so the new end date of the project is 30/04/2025.
DetailsMeet the team behind c4c! We are a diverse group of people from many different backgrounds, all working towards a common goal: better medicines for children through European clinical trials. Today’s spotlight is on Ricardo Fernandes, from the University of Lisbon and AIDFM.
DetailsDefining how meaningful Patient and Public Involvement (PPI) is realised in practice, (especially where child and young patients are concerned) is limited partly due to the low-level reporting of the processes and outputs of PPI activities in general.
Details
